1A9bnbK
1A9bnbK
1A9bnbK
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
***<br />
EXECUTIVE SUMMARY<br />
xi<br />
EXECUTIVE SUMMARY<br />
Introduction<br />
Investing to overcome the global impact of neglected tropical diseases charts new ground<br />
in tackling the 17 neglected tropical diseases (NTDs) that affect more than a billion<br />
people in 149 countries worldwide. It makes the case for domestic investment to reach the<br />
targets of WHO’s Roadmap on NTDs by 2020 and sustain enhanced, equitable access to<br />
high-quality coverage against these diseases to 2030.<br />
This third WHO report anticipates the investments needed as countries graduate from<br />
low-income to middle-income status and as the world’s focus expands from the Millennium<br />
Development Goals to the Sustainable Development Goals.<br />
Confronting challenges, registering progress<br />
In May 2013, the Sixty-sixth World Health Assembly adopted resolution WHA66.12 on<br />
neglected tropical diseases. To ensure that the Resolution has greatest impact, partners,<br />
stakeholders and academia are encouraged to generate further momentum for transforming<br />
its recommendations into reality.<br />
This report discusses the progress achieved to date. More than 74 countries worldwide<br />
are ready to implement national NTD master plans, stimulating increased demand for<br />
programme implementation and donated medicines – crucial to reaching the Roadmap’s<br />
targets. More people than ever received preventive treatment for at least one disease in 2012.<br />
Globally, a total of 27 countries have achieved the target of 75% treatment coverage of schoolage<br />
children for soil-transmitted helminthiases. Sustained efforts over the past 15 years<br />
have reduced the number of new cases of human African trypanosomiasis by 90%. In 2013,<br />
Colombia became the first country in which WHO verified the elimination of onchocerciasis<br />
(river blindness), followed by Ecuador in 2014. Bangladesh is poised to eliminate visceral<br />
leishmaniasis as a public-health problem. China has sustained its national schistosomiasis<br />
control programme and interrupted transmission in most endemic areas. Since 2006, more<br />
than 5 billion anti-parasitic treatments, mostly donated by the pharmaceutical industry,<br />
have been delivered to populations in need.<br />
Although support from major donors continues and important progress has been<br />
achieved, challenges remain. While this report focuses on the need for enhanced domestic<br />
investment, it considers what the universal health coverage (UHC) targets imply for NTD<br />
programmes in terms of population coverage with prevention and financial risk-protection<br />
against the cost of treatment and care.